Lv42
498 积分 2022-07-26 加入
Specific and selective induction of miR-124 in immune cells by the quinoline ABX464: a transformative therapy for inflammatory diseases
5天前
已完结
A Novel Colon PBPK Model: Navigating the Rational Drug Design for Small-Molecule Colon-Selective Therapies
8天前
已完结
Microneedle Patch Delivery of PROTACs for Anti-Cancer Therapy
8天前
已完结
Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER)
8天前
已完结
Long lasting control of viral rebound with a new drug ABX464 targeting Rev – mediated viral RNA biogenesis
12天前
已完结
PROTAC based targeted degradation of LRG1 for mitigating corneal neovascularization
23天前
已完结
52243 AH-001: An Emerging Androgen Receptor Degrader Showing Therapeutic Potential in Addressing Androgenetic Alopecia (AGA)
23天前
已关闭
Discovery of a Novel Non-invasive AR PROTAC Degrader for the Topical Treatment of Androgenetic Alopecia
24天前
已完结
PROTAC Degraders of Androgen Receptor‐Integrated Dissolving Microneedles for Androgenetic Alopecia and Recrudescence Treatment via Single Topical Administration
24天前
已完结
A Top-Down Design Approach for Generating a Peptide PROTAC Drug Targeting Androgen Receptor for Androgenetic Alopecia Therapy
24天前
已完结
皖公网安备34019202002308
